Pharmaceuticals

Drug Development Biotechnology Acquisitions Manufacturing Drug Pricing Drug Manufacturing Vaccine Development Biopharmaceuticals Market Trends Pharmaceutical Companies

Florida Sues Pfizer and CEO Over COVID-19 Vaccine Marketing

The state alleges the company hid safety risks and misled consumers and is asking for fines, profit returns and a court order to stop the conduct.

Sanofi Expands Regeneron Collaboration With $1 Billion Upfront for Four Antibody Programs

HHS and ARPA-H Launch SURPASS to Rebuild U.S. Clinical Trials

Court Rules Liquidia’s Yutrepia Infringes United Therapeutics Patent

AstraZeneca Buys Stake in Summit to Pursue Cancer Drug Combinations

Novo Nordisk Licenses Chinese Oral GLP‑1/GIP Obesity Pill for Up to $2.6 Billion

Merck Closes $2.13 Billion License for SciBrunch KRAS G12D Drug Candidate

Nanexa Licenses PharmaShell to Novo Nordisk in Deal Worth Up to €1.17 Billion

Lilly and InnoCare Agree Discovery Pact Valued at Up to $3.35 Billion

Basecamp Research Raises $140 Million to Push EDEN AI Toward In‑Vivo Cell Therapies

Novo Sets Bold 2030 Targets but Shares Slide After Investors Question Pipeline

Lilly Says Foundayo Now Drives One-Third of New Oral GLP-1 Starts as It Breaks Ground on $6.5 Billion Houston Plant

HHS Moves to Shift U.S. Biomedical Research From Animal Tests to Human-Based Methods

Trump Demands Some Childhood Vaccines Be Split Into Five Doses

Xenon Submits NDA for Epilepsy Drug as Psychiatric Trials Pause After Safety Signals

Novo Nordisk Teams With Anthropic to Test Claude for Drug Discovery

Novo Nordisk Becomes 'Novo' as CEO Launches Cultural Reset

Gotistobart Extends Survival in Early PRESERVE‑003 Update

Definium’s LSD-Based Therapy Posts Third Positive Phase 3 Result in GAD

Novartis Faces Investor Backlash After Second Late‑Stage Trial Failure